 Connection
Christopher Lowry to Central Nervous System
This is a "connection" page, showing publications Christopher Lowry has written about Central Nervous System.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.862 |
|
|
|
-
Flux MC, Lowry CA. Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience. Neurobiol Dis. 2020 02; 135:104578.
Score: 0.585
-
Hale MW, Rook GA, Lowry CA. Pathways underlying afferent signaling of bronchopulmonary immune activation to the central nervous system. Chem Immunol Allergy. 2012; 98:118-41.
Score: 0.356
-
Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med. 2006 Aug 31; 8(20):1-27.
Score: 0.238
-
de Vries A, Paton JF, Lightman SL, Lowry CA. Characterisation of c-Fos expression in the central nervous system of mice following right atrial injections of the 5-HT3 receptor agonist phenylbiguanide. Auton Neurosci. 2005 Dec 30; 123(1-2):62-75.
Score: 0.225
-
Frank MG, Fonken LK, Dolzani SD, Annis JL, Siebler PH, Schmidt D, Watkins LR, Maier SF, Lowry CA. Immunization with Mycobacterium vaccae induces an anti-inflammatory milieu in the CNS: Attenuation of stress-induced microglial priming, alarmins and anxiety-like behavior. Brain Behav Immun. 2018 10; 73:352-363.
Score: 0.134
-
Hale MW, Raison CL, Lowry CA. Integrative physiology of depression and antidepressant drug action: implications for serotonergic mechanisms of action and novel therapeutic strategies for treatment of depression. Pharmacol Ther. 2013 Jan; 137(1):108-18.
Score: 0.091
-
Rook GA, Lowry CA, Raison CL. Lymphocytes in neuroprotection, cognition and emotion: is intolerance really the answer? Brain Behav Immun. 2011 May; 25(4):591-601.
Score: 0.080
-
Rook GA, Lowry CA. The hygiene hypothesis and psychiatric disorders. Trends Immunol. 2008 Apr; 29(4):150-8.
Score: 0.066
-
Mac Giollabhui N, Foster S, Lowry CA, Mischoulon D, Raison CL, Nyer M. Interleukin-6 receptor antagonists in immunopsychiatry: Can they lead to increased interleukin-6 in the central nervous system (CNS) and worsening psychiatric symptoms? Brain Behav Immun. 2022 07; 103:202-204.
Score: 0.044
-
Tizenberg BN, Brenner LA, Lowry CA, Okusaga OO, Benavides DR, Hoisington AJ, Benros ME, Stiller JW, Kessler RC, Postolache TT. Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19. Curr Psychiatry Rep. 2021 10 01; 23(10):68.
Score: 0.042
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|